HYDERABAD, India–(BUSINESS WIRE)–#AnalyticalDevelopment–Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading integrated contract researchHYDERABAD, India–(BUSINESS WIRE)–#AnalyticalDevelopment–Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading integrated contract research

Sai Life Sciences to Recruit 700+ Professionals in FY27

2026/02/20 17:15
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

HYDERABAD, India–(BUSINESS WIRE)–#AnalyticalDevelopment–Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading integrated contract research, development and manufacturing organizations (CRDMOs), today announced plans to hire 700+ scientific, technical, and management professionals during 2026–27 as it scales capabilities to meet growing global demand for end-to-end drug discovery, development and manufacturing services.

The recruitment will span roles across medicinal chemistry, biology, DMPK, process and analytical development, formulation development, process engineering, technology transfer, quality, peptides, business development, program management, and manufacturing, among others.

A specific area of focus through this recruitment drive will be on attracting high-calibre scientists from leading institutions in India and globally, reflecting the increasing complexity of programs being entrusted to Sai Life Sciences and the higher scientific expectations placed on Indian CRDMOs by global innovator companies.

Making the announcement, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said: “We are at an inflection point for the Indian CRDMO industry. Global supply-chain rebalancing, the need for resilient development and manufacturing partners, and the rising sophistication of outsourced science are converging in India’s favour. Demand for high-quality, integrated partners is already visible, and this expansion is about preparing ourselves to serve that demand at scale — with the right infrastructure, strong digital and quality systems, and deep scientific capability.”

Krishna added, “For scientists, this is a genuinely exciting moment. They have the opportunity to work on globally relevant, high-impact programs while being based in India. We believe this phase of growth creates a compelling opportunity for Indian scientists anywhere in the world to consider building the next chapter of their careers here—without compromising on scientific rigor, exposure, or the quality of work.”

The new roles will support growing activity in areas such as complex small-molecule synthesis, high-throughput experimentation, data-enabled drug discovery, and late-stage CMC and commercial manufacturing scale-up.

As part of its talent strategy, Sai Life Sciences has launched a global alumni engagement platform and is strengthening learning, leadership development, and internal mobility programs to support long-term career growth.

Sai Life Sciences operates across India, the UK, and the US, serving global pharmaceutical and biotechnology companies. Its Manchester site focuses on process R&D, while its Boston Biology facility supports early discovery collaborations and client engagement. The majority of new roles will be based in Hyderabad, home to the company’s largest integrated R&D campus. With more than 3,400 scientists and professionals currently on board, the planned hiring reflects its continued growth and its expanding role as a global CRDMO partner.

About Sai Life Sciences

Sai Life Sciences is a full-service CRDMO working with innovator pharma and biotech companies globally to accelerate the discovery, development, and commercialization of small molecules. With operations across India, the UK, and the US, Sai Life Sciences offers scientific expertise, world-class infrastructure, and a culture of excellence focused on quality, safety, and sustainability. www.sailife.com

Contacts

For further information, contact:

Sriram Gopalakrishnan
Vice President, Corporate Communications
Sai Life Sciences  
Ph: +91 9121295355
[email protected]

Market Opportunity
Sharpe AI Logo
Sharpe AI Price(SAI)
$0.0009114
$0.0009114$0.0009114
-0.25%
USD
Sharpe AI (SAI) Live Price Chart

Get Covered, Share 1M USDT

Get Covered, Share 1M USDTGet Covered, Share 1M USDT

Higher VVIP tiers, higher compensation odds.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Not a loophole: Singapore AI export controls let China tap US AI legally

Not a loophole: Singapore AI export controls let China tap US AI legally

American AI technology is reaching Chinese tech giants through a route that US export controls were never designed to close: Singapore. The city-state sits outside
Share
The Cryptonomist2026/07/10 14:46
Ondo Finance Launches USDY Yieldcoin on Stellar, Bringing Tokenized U.S. Treasuries to Users

Ondo Finance Launches USDY Yieldcoin on Stellar, Bringing Tokenized U.S. Treasuries to Users

Ondo Finance, a U.S.-based digital asset firm specializing in bringing traditional financial products on-chain through tokenization, is expanding its yieldcoin USDY to the Stellar network. This lates update marks a step forward in merging tokenized real-world assets with a global payments infrastructure, unlocking new opportunities for users worldwide. The announcement was made at the Stellar Meridian event in Copacabana, Rio de Janeiro, on September 17. USDY Joins the Stellar Ecosystem Ondo Finance, a recognized leader in tokenized real-world assets, announced the deployment of United States Dollar Yield (USDY) on Stellar, the payments-focused blockchain known for speed and low transaction costs. USDY is the most widely available “yieldcoin,” offering investors access to onchain assets backed by U.S. Treasuries. This launch allows Stellar’s global user base to tap into permissionless, yield-bearing assets tied to one of the safest financial instruments in the world. It also aligns with Stellar’s mission of driving fast, affordable cross-border payments. Combining Yield with Payments Infrastructure “Stablecoins unlocked global access to the U.S. dollar. With USDY, we’re taking the next step by bringing U.S. Treasuries onchain in a form that combines stability, liquidity, and yield,” said Ian De Bode, Chief Strategy Officer at Ondo Finance. “Fast, affordable cross-border payments are at the center of what Stellar was designed to do. The global reach of the Stellar ecosystem combined with a yield-bearing asset like USDY levels up what is possible onchain, allowing wallets and businesses to offer yield opportunities to their users,” said Denelle Dixon, CEO of the Stellar Development Foundation. Ondo claims by pairing USDY with Stellar’s infrastructure, new possibilities open up in treasury management, collateralization, and everyday financial applications. Unlocking Institutional and Retail Use Cases USDY currently manages over $650 million in total value locked (TVL) across nine blockchains and offers a 5.3% APY. By launching on Stellar, Ondo Finance extends these benefits to global retail and institutional users. The firm explains balances on Stellar can now become productive, supporting use cases such as onchain savings, institutional treasury strategies, cost-efficient collateral for DeFi protocols, and remittance flows that carry yield rather than remaining static. A Milestone for Tokenized Treasuries With the integration of USDY, Stellar users gain more than just access to stable-value assets—they gain access to institutional-grade yield. For investors outside the U.S., the launch represents a new way to combine the safety of Treasuries with the accessibility of blockchain technology. As tokenization accelerates globally, Ondo Finance’s decision to deploy USDY on Stellar reinforces the narrative that blockchain is not just about speculation, but about reimagining the global financial system through secure, yield-bearing digital assets
Share
CryptoNews2025/09/18 00:46
Q2 Market Insights: Bitcoin regains dominance in risk-averse environment, ETFs remain critical to market structure

Q2 Market Insights: Bitcoin regains dominance in risk-averse environment, ETFs remain critical to market structure

The market will show a downward trend in the short term, and then rebound and set new highs in the second half of the year.
Share
PANews2025/04/28 19:40

Record Ads, Stock Down 7%

Record Ads, Stock Down 7%Record Ads, Stock Down 7%

Jul 29: Meta earnings face the market's question.